ARTICLE | Clinical News
Atacand candesartan cilexetil regulatory update
July 12, 2004 7:00 AM UTC
AZN submitted an sNDA to FDA for Atacand to treat patients with chronic heart failure. The angiotensin II receptor antagonist is approved to treat hypertension. ...